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Abstract. Rabbit synovial fibroblasts (RSF) express 
basal levels of the metalloproteinases (MMP) col- 
lagenase, stromelysin-1 and 92-kD gelatinase when 
plated on intact fibronectin (FN), but elevated levels 
when plated on either the central RGD-containing 
cell-binding region of FN (120FN) or antibody against 
the ot5/~l integrin, suggesting that domains outside 
120FN may suppress the induction of MMP (Werb, 
Z., P. M. Tremble, O. Behrendtsen, E. Crowley, and 
C. H. Damsky. 1989. J. Cell Biol. 109:877-889). We 
therefore attempted to reconstitute he basal signaling 
of intact FN by plating RSF on 120FN together with 
domains of FN outside this region. Large COOH-ter- 
minal fragments containing both the heparin-binding 
and IIICS domains uppressed MMP when combined 
with 120FN. To map the active sequences, peptides 
from this region and larger fragments that did, or did. 
not, include the CS-1 portion of IIICS were tested. 
Only CS-1 peptide, or larger fragments containing 
CS-1, suppressed MMP expression i duced by 120FN. 
In contrast, peptide V from the heparin-binding region, 
shown previously to stimulate focal contact formation, 
further enhanced MMP expression by RSF when pres- 
ent on the substrate with 120FN. RSF expressed ot4B1 
integrin, the receptor for CS-1, and the anti-tx4 mAb 
blocked the ability of CS-1 to suppress MMP induc- 
tion by 120FN. These results show that signals mod- 
ulating MMP expression and focal contact assembly 
are regulated independently, and that cooperative sig- 
naling by ot5/51 and ot4~l integrins plays a dominant 
role in regulating expression of these extracellular ma- 
trix-remodeling genes in response to FN. This work 
demonstrates directly the modular way in which infor- 
mation in the extracellular matrix is detected and 
processed by cell surface receptors. 
C 
ELLS interact with the extracellular matrix (ECM) ~ 
via several classes of cell surface receptors (reviewed 
in Albelda and Buck, 1990; Yamada, 1991; Hynes, 
1992). Their responses to ECM are varied and include adhe- 
sion, spreading, migration, and differentiation. In addition 
to these morphogenetic effects, recent studies have shown 
that the composition and organization of the ECM can regu- 
Address all correspondence to P. Huhtala, HSW 604, Department of 
Stomatology, 513 Parnassus Avenue, University of California, San Fran- 
cisco, CA 94143-0512. Ph.: (415)476-8921. Fax: (415)476-4204. 
1. Abbreviations used in this paper: CM, conditioned medium; CS, con- 
netting segment; CSPG, chondroitin sulfate proteoglycan; ECM, extra- 
cellular matrix; FN, fibronecfin, GAPDH, glyceraldehyde-3-phosphate 
dehydrogenase; HBD, heparin-binding domain; HSPG, heparan sulfate pro- 
teoglycan; LH, lactalbumin hydrolysate; MMP, matrix metalloproteinase; 
OA, ovalbumin; RGD, Arg-Gly-Asp; RSF, rabbit synovial fibroblast; 
120FN, 120-kD fragment of fibroneetin; 33166FN, 33- and 66-kD COOH- 
terminal fragments of FN; 29FN, 29-kD fragment of FN. 
late the expression of genes that play important roles in 
tissue-specific differentiation, growth, pH regulation, and 
matrix remodeling (reviewed in Damsky and Werb, 1992; 
Adams and Watt, 1993; Ashkenas et al., 1994). 
The information encoded in ECM is transduced by cells 
through combinations of interactions between individual 
ECM ligand-binding sites and cell surface receptors. The 
ECM as a whole is extremely complex, with many different 
components exhibiting the ability to bind to cells as well as 
to other ECM constituents. Recently it has become clear that 
cell contact with even one specific ECM component, such 
as fibronectin (FN), initiates multiple signals affecting both 
cell behavior and gene xpression. Little is known about how 
ceils process the complex input from the engagement of 
different combinations of receptors and binding sites on an 
individual ECM ligand. However, the non-redundant nature 
of the multiple interactions between different receptors and 
a single ECM component has been underscored recently by 
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the observation that targeted null mutations in the genes for 
FN (George t al., 1993), or for either of its two major inte- 
grin receptors, ot5/31 (Yang et at., 1993) and c~4~1 (Yang et 
al., 1994), display distinct phenotypes, and they are all lethal 
early in development. 
Dissection of the structure-function relationships ofa sin- 
gle ECM component is most advanced for FN. FN com- 
prises a family of polypeptides that results from the alterna- 
tive splicing of a single RNA (reviewed in Hynes, 1990; 
Schwarzbauer, 1991). FN can interact extensively with itself, 
and with other matrix components hrough its collagen-, 
fibrin- and glycosaminoglycan-binding omains. Remark- 
ably, at least eight peptide sequences with varying cell sur- 
face binding activities have been mapped to different regions 
of FN (see Fig. 1). These sites on FN have been shown to 
interact with at least two distinct classes of cell surface 
receptors: integrins and membrane-associated proteogly- 
cans (reviewed in Yamada, 1991; Damsky and Werb, 1992). 
The NH2-terminal 29-kD domain, containing the first five 
type I repeats (II-~), is required for assembly of a fibrillar 
FN matrix. It has fibrin- and weak heparin-binding activi- 
ties and it binds weakly to the cell surface (Limper et al., 
1991; Moon et al., 1994). However, no specific ell surface 
receptor has been identified. A large, chymotrypsin-derived, 
central cell-binding region with relatively high cell-binding 
activity (approximately III3-~') contains the Arg-Gly-Asp 
(RGD) sequence in III '° and additional synergy sequences 
in Ill 9 that are important for receptor specificity and bind- 
ing activity (Aota et al., 1994; Bowditch et at., 1994). This 
region is recognized by several integrin family members, in- 
cluding the "classical" ct5fll FN receptor, c¢3/31, c~v/31, ave3, 
and ctvB6 integrins (reviewed in Yamada, 1991; Damsky and 
Werb, 1992). Several sites that are COOH-terminal to the 
central cell-binding domain of FN also interact with the cell 
surface. Several peptides from the major heparin-binding 
domain (HBD) of FN (III ~2-~4) support cell attachment with 
varying affinities, and specific cell surface heparan sulfate 
proteoglycans (HSPG) and chondroitin sulfate proteoglycans 
(CSPG) have been identified as putative receptors (McCar- 
thy et al., 1988; Drake et at., 1992; Iida et at., 1992; Lories 
et al., 1992; Woods et al., 1993; Giuseppetti et al., 1994). 
The III '4 also has a low affinity binding site for ot4~l inte- 
grin (Mould and Humphries, 1991). Finally, COOH-terminal 
to the HBD is the so-called connecting segment (IIICS) or 
variable (V) region, which has a complex pattern of alterna- 
tive splicing (reviewed in Hynes, 1990; Schwarzbauer, 
1991). It contains ot4Bl-binding sites, CS-1 and CS-5, of 
which CS-1 is a high affinity binding sequence (Wayner et 
al., 1989; Guan and Hynes, 1990; Mould et al., 1990, 1991). 
The CS-1 site is also recognized by the c¢4/~7 integrin (Erie 
et al., 1991; Ruegg et at., 1992). 
For the information encoded in the different domains of 
FN to have an impact on the cell, receptors on the cell sur- 
face must be able to detect and integrate the diverse cues 
arising from the interaction with FN. One example of their 
ability to do so comes from Woods et al. (1986), who showed 
that formation of focal contacts by human primary fibro- 
blasts is a result of signals from both the central cell- and 
heparin-binding regions of FN. 
Previous tudies from our group have shown that rabbit sy- 
novial fibroblasts (RSF) respond to subtle changes in the 
composition of the ECM by regulating their expression of 
several ECM-degrading matrix metalloproteinases (MMP; 
Werb et at., 1989; Tremble t at., 1993, 1994). For example, 
these cells express basal levels of interstitial collagenase 
(MMP-1) and stromelysin-1 (MMP-3) following synthesis of 
an endogenous matrix in culture or after plating on intact 
FN. However, expression of these nzymes i induced when 
cells are plated on immobilized RGD-containing peptides, 
on the chymotryptic central cell-binding fragment of fibro- 
nectin (120FN), or on an immobilized antibody to the or5 
subunit of the ot5~/1 fibronectin receptor (BIIG2; Werb et at., 
1989). Taken together, these data suggest the hypothesis that 
the 120FN-c~5~I interaction provides an inductive signal for 
MMP expression which is overridden by additional signal(s) 
arising from the interaction of domain(s) of fibronectin out- 
side the central cell-binding region with as yet unidentified 
cell surface receptor(s). 
In the present study we tested this hypothesis and now re- 
port that the presence of the CS-1 sequence from the IIICS 
region of FN on the substrate along with 120FN provides 
sufficient information for maintaining the low basal evels of 
MMP expression characteristic of RSF in contact with intact 
FN. Furthermore, we show that this regulation is mediated 
by the interaction of the ot4/31 integrin with the CS-1 region. 
Finally, we have found that a distinct sequence, peptide V, 
within the COOH-terminal HBD, shown previously to stim- 
ulate focal contact formation by normal fibroblasts (Woods 
et at., 1993), can stimulate MMP expression above the level 
induced by 120FN alone. 
Materials and Methods 
Ce//s 
RSFs were isolated as described previously (Aggeler el al., 1984) and cul- 
tured in DME (Cell Culture Facility, University of California, San Fran- 
cisco, CA) supplemented with 10% FBS (Hyclone, Denver, CO). RSF were 
used between passages 2 and 7, and they were subcoltured 48 h before ex- 
perimental procedures. At least five different cell lines derived from differ- 
ent rabbits were used in these experiments. 
ECM Ligands 
The FN fragments and peptides used, and their position in intact plasma 
FN, are shown in Fig. 1. Human plasma FN was purchased from 
Boehringer-Mannheim Biochemicals (Indianapolis, IN), and chymotryptic 
120-kD fragment of FN (120FN) was purchased from GIBCO BRL 
(Gaithersburg, MD). Both were reconstituted according to the manufac- 
turers' instructions and stored at -700C in single-use aliquots. When 
checked with SDS-PAGE and Coomassie blue staining, more than 95% of 
the protein in each product had the molecular mass of intact FN or of the 
120FN fragment, respectively. The COOH-terminal FN fragments used 
were from two different sources. A mixture of 33- and 66-kD fragments of 
FN (33/66FN), the region COOH-terminai to the cell-binding domain, was 
produced from human plasma FN using trypsin and cathepsin D and 
purified as described previously (McCarthy et al., 1988). This region con- 
tains both the COOH-terminal HBD (IIP 2-~4) and a part of the IIICS cell- 
binding segment. Purified recombinant fragments containing the COOH- 
terminal heparin-binding domain with or without he adjacent IIICS region 
(H120 and HO), or without either the CS-1 (H95) or CS-5 (H89) sequences, 
were expressed and purified as described previously (Makarem et al., 1994; 
Mould et al., 1994). These fragments all contain repeats II112-15. 
The NHe-terminal 29-kD fragment of FN (29FN) was purified from 
conditioned medium (CM) of CHO cells transfected with a construct con- 
taining the rat 29-kD NHz-terminal fragment under control of a metal- 
lothionein promoter. These cells were a giR from P. Johnson (University 
of California, San Francisco, CA). Briefly, CHO cells were cultured in FI2 
medium with 10% FBS until subconfluency. Cells were washed with PBS 
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Figure 1. Schematic diagram of intact plasma FN and location of 
fragments and synthetic peptides used in this study. Locations of 
peptides are shown by arrows. See Materials and Methods for de- 
tails of origins of peptides and fragments. Binding activities of the 
individual FN domains are indicated. 
to remove serum and changed to serum-free FI2 medium. CM was col- 
lected after 3 d, dialyzed in 500 ml fractions in TE (50 mM Tris-HCl, 1 
mM EDTA, pH 7.5), and then passed through 20 mi of DEAE-Sepharose 
(Pharmacia, Piscataway, NJ) equilibrated in TE. The flow-through, con- 
taining the 29FN, was applied subsequently to a 10-ml CM-Sepharose 
column (Pharmacia, Piscataway, NJ). After the column was washed with 
several column volumes of TE to remove all unbound protein, the 29FN 
was eluted with DME containing 150 mM NaCI. SDS-PAGE and Coomas- 
sic brilliant blue staining and Western analysis with polyclonal anti-FN an- 
tibody (Telios Corporation, La Jolla, CA) were used to monitor the 
purification of the fragment. The 29FN-containing fractions were dialyzed 
against DME. The purification protocol resulted in preparations showing 
two closely spaced proteins of 29 kD, both of which stained with anti-FN 
antibody (data not shown). Fragment preparations were further filtered 
through 0.2-tLm-pore Millex filters (Miilipore Corp., Bedford, MA) and 
stored in aliquots at -70°C. Purified fragments from four different prepara- 
tions were used in the experiments. 
The synthetic peptides corresponding toparticular regions of the COOH- 
terminal HBD and IIICS included: peptide I (FN-C/HI; YEKPGSPPRE- 
VVPRPRPGV), peptide II (FN-C/HII; KNNQKSEPLIGRKKT), peptide 
III (FN-C/HIII; YRVRVTPKEKTGPMKE), peptide IV (FN-C/HIV; SPP- 
RRARVT), peptide V (FN-C/HV; WQPPRARI) (McCarthy et al., 1988; 
Iida et al., 1994), CS-1 (DELPQLVTLPHPNLHGPEILDVPST) (Hum- 
phries et al., 1986), and scrambled versions of peptides CS-1 (scr-CS-I) and 
peptide V (scr-peptide V). The positions of these peptides in intact plasma 
FN are shown in Fig. 1. Peptides were chemically conjugated to ovalbumin 
(OA) using l-ethyl-3(3-dimethylaminopropyl)carbodiimide hydrochloride 
(EDC) (Sigma Chem. Co.) as described previously (Humphries et al., 
1987; Haugen et al., 1990). Briefly, equal amounts of peptide and OA were 
solubilized in water and mixed with a 10-fold excess (by weight) of EDC 
dissolved in water. The mixture was rotated overnight at 4°C. The coupled 
peptides were dialyzed (10-14-kD exclusion dialysis membrane; Spectrum 
Medical Industries, Houston, TX) extensively against PBS to remove ex- 
cess EDC. The dialyzed peptides were filtered, aliquoted and stored at 
-70°C. At least two conjugates of each peptide were prepared, and each 
pair had the same biological activity in assays. A control conjugate was pre- 
pared by cross-linking OA to itself. 
Preparation of ECM Ligand Substrates and 
Assay Conditions 
Culture dishes (24- or 48-well culture dishes; Costar Corp., Cambridge, 
MA) were incubated with FN or 120FN at 30/~g/mi in PBS for 8-16 h at 
4"C. Wells were ~irashed three times with PBS, and nonspocific adhesion 
to the tissue culture dish was blocked with 0.2% BSA in PBS for 1 h. The 
wells were washed three times with PBS prior to plating cells. To prepare 
mixed substrates, other fragments of FN (29FN, 33/66FN, H120, H0, H89, 
H95) were co-coated with 120FN and FN in various concentrations (10-30 
/~g/ml). Synthetic poptides conjugated to OA were also co-coated with FN 
and 120FN, at concentrations of 10-200/~g/ml, using the protocol shown 
for FN. RSF were plated on substrate-coated wells at a density of 0.5-1 x 
10~/cm 2 in serum-free DME supplemented with 0.2% lactalbumin 
hydrolysate (DME-LH). Cells were incubated on the substrates for 18 h and 
supernatants were collected. In some experiments RSF were pretreated with 
antibodies (5 ~g/mi) for 30 min before plating. 
Antibodies 
Mouse mAbs against rabbit collagenase have been described previously 
(Werb et al., 1989). Mouse mAb against stromelysin-1 (Wilhelm et al., 
1992) was a gift from Dr. Scott Wilhelm (Miles Research, West Haven, 
CT). Rabbit polyclonal antibodies were generated against COOH-terminal 
FN fragments (33/66FN) by injecting New Zealand White rabbits first with 
10 ~g of fragment emulsified in complete Freund's adjuvant, followed by 
biweekly injections of antigen in incomplete Freund's adjuvant. The rabbits 
were bled, IgG was purified by ion exchange chromatography, and the 
immunologic reactivity of the purified IgG was verified by ELISA as de- 
scribed previously (McCarthy et al., 1990). Mouse mAb against human u4 
subunit (L25) (Clayberger et al., 1987; Mclntyre et al., 1989) was kindly 
provided by B. Mclntyre (MD Anderson Cancer Center, University of 
Texas, Houston, TX). Mouse mAb against human u5 subunit (IVF4) was 
a gift from R. Isberg (Tufts University, Boston, MA). Anti-vinculin mAb 
was purchased from Sigma Chem. Co. 
Analysis of Specific Proteinases 
Samples of CM (30/zl) were separated by SDS-PAGE, and proteins were 
transferred to nitrocellulose membranes (BioRad Laboratories, Hercules, 
CA). Collagenase and stromelysin were detected by using specific mAbs 
with enhanced chemiluminescence as described previously (Tremble t al., 
1994). Specific bands were scanned with LKB densitometer and GSXL 
software (LKB-Pharmacia, Piscataway, NJ). In many experiments a
slot-blot filtration manifold (BioRad Laboratories) was used to apply serial 
dilutions of CM on membranes toallow better quantification ofcollagenase 
levels. 
In some experiments, RSF were cultured in DME-LH for 16 h, after 
which CM was removed and RSF were metabolically abeled by incubation 
with 50-100/zCi/ml [35S]methionine (Express Label; New England Nu- 
clear, Boston, MA) for 4-5 h in methionine-free DME. CM was collected, 
and radiolabeled secreted proteins were precipitated with quinine sulfate 
and SDS or immunoprecipitated with anti-collaganase antibodies as de- 
scribed previously (Werb et al., 1989). Precipitated proteins were analyzed 
by SDS-PAGE followed by autoradiography. 
Gelatinase activities present in 25-/~1 aliquots of CM were assayed by 
zymography as described previously (Herron et al., 1986; Werb et al., 
1989). 
RNA Isolation, Hybridization, and cDNA Probes 
RSF were cultured for 24 h on substrates on 60-mm cell culture dishes. To- 
tal RNA was isolated using the isothiocyanate-phenol-chloroform extraction 
method (Chomczynski and Sacchi, 1987). Northern blot hybridization anal- 
yses were performed according to standard procedures (Sambrook et al., 
1989) with QuickHyb hybridization solution (Stratagene Corp., La Jolla, 
CA) and Redivue DNA labeling system with Redivue [32p]dCTP (Amer- 
sham Corp.). Membranes were probed with a 32p-labeled rabbit col- 
lagenase cDNA clone pCL1 (Frisch et al., 1987). A cDNA probe specific 
for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an 
internal control. 
Immunofluorescence 
RSF were plated on acid-washed coverslips coated with various ECM ligand 
substrates a  described above. Coverslips were washed with PBS, fixed with 
3% paraformaldehyde, p rmeabilized with acetone, and stained with anti- 
body as described previously (Werb et al., 1989; Tremble et al., 1993). 
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Figure 2. Collagenase expression by RSF plated on fragments of FN. (A) RSF were plated in DME-LH in wells that had been coated 
with FN (lanes I and 2), 120FN (lanes 3 and 4), or 120FN + 33/66FN (lanes 5 and 6) and incubated for 18 h. Samples of CM containing 
secreted proteins were separated by SDS-PAGE and the proteins were transferred to membranes and analyzed by immunoblotting with 
anti-collagenase mAb. Collagenase is indicated by arrows. Molecular weight markers (xl0 -3) are indicated at the left. (B) RSF were 
plated on FN, FN + 33/66FN, FN + 29FN, 120FN, 120FN + 33/66FN, and 120FN + 29FN. Samples of CM from cultures grown 
on these substrates for 18 h were analyzed by immunoblotting with anti-collagenase mAb and quantified by densitometry. The data are 
expressed as fold in uction, where expression of collagenase by RSF cultured on FN was normalized to 1.The data re mean + SEM 
from five to seven different experiments, each in duplicate. (C) Collagenase expression by RSF plated on FN in the presence of polyclonal 
antibodies against he COOH-terminal regions of FN. RSF were plated inwells coated with FN and incubated for 18 h with antibodies. 
Cultures were metabolically labeled with [35S]methionine for 5 h and radiolabeled secreted proteins were analyzed by SDS-PAGE. RSF 
with control antibody at 100 #g/ml (lanes 1 and 2), without antibodies (lanes 3 and 4), or with anti-33/66FN Ab at 100 ~g/ml (lanes 
5 and 6). Proteins immunoprecipitated with collagenase mAb from CM from cultures grown on FN (lane 7), 120FN (lane 8), and on 
FN with anti-33/66FN antibody (lane 9). The collagenase doublet is indicated by arrows. Molecular weight markers (xl0 -3) are indi- 
cated at the left. (D) Regulation of coUagenase mRNA expression i  RSF plated on various FN substrates for 24 h. Total RNA from RSF 
plated on FN (lane 1), 120FN (lane 2), and 120FN + 33/66FN (lane 3) was hybridized with 32p-labeled collagenase and GAPDH 
cDNAs. The amount of collagenase mRNA was normalized with the GAPDH mRNA, and the amount of collagenase mRNA on 120FN 
was set o 1. 
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Figure 3. Expression of 92-kD gelatinase and stromelysin-1 by RSF plated on a mixed substrate of 120FN and 33/66FN. RSF were plated 
in DME-LH in wells coated with FN (lanes 1 and 2), 120FN (lanes 3 and 4), and 120FN + 33/66FN (lanes 5 and 6) and incubated 
for 18 h. (A) The CM was analyzed by gelatin zymography. Proteolytic degradation of gelatin appears as clear zones. 92- and 72-kD 
gelatinases are indicated by arrows. Molecular weight markers (xl0 -3) are indicated at the left. (B) The CM was analyzed by SDS-PAGE 
and immunoblotting with stromelysin-1 mAb. Stromelysin-1 is indicated by an arrow. 
Biotinylation of Cells and Immunoprecipitations 
RSF were cultured in DME supplemented with 10% FBS until confluency. 
Cells were surface labeled with biotin and cell lysates prepared as described 
previously (Stephens et al., 1993). Lysates from 1 x 106 cells were immu- 
noprecipitated with anti-u4 and -c~5 antibodies, and immunoprecipitated 
biotinylated proteins were separated by SDS-PAGE, blotted, and visualized 
using enhanced chemiluminescence a cording to the manufacturer's in-
structions (Amersharn Corp.). 
Cell Adhesion Assays 
96-well plates were coated with OA-conjugated CS-1 and V peptides at 50 
~g/ml in PBS for overnight at 4"C. Wells were washed and nonspecific 
adhesion blocked as described above. RSF were trypsinized, washed with 
medium containing 0.2% soybean trypsin inhibitor (Sigma Chem. Co.), 
and then incubated with or without anti-~x4 antibodies (5/xg/rnl) for 30 min 
prior to plating on substrates. Plated RSF were incubated for 30 min to per- 
mit attachment, shaken on an orbital shaker at 250 rpm for 30 s and washed 
with PBS. Cells on substrates were photographed both before and after 
shaking. 
Results 
A Mixed Substratum ofl2OFN and the 
COOH-termina133/66FN Region of FN, but Not the 
NHz-termina129FN Region, Reconstitutes th  
Suppressive Effect of FN for MMP Expression 
The first goal of this study was to ascertain which regions 
of FN outside the central cell-binding domain were impor- 
tant in determining MMP gene expression i RSE Because 
intact FN is not inductive for collagenase expression whereas 
120FN is (Werb et al., 1989), we first determined whether 
regions NH2- or COOH-terminal to the 120FN central cell- 
binding domain added in trans could restore the response of 
RSF to that displayed on intact FN. We plated cells on intact 
FN, or on a substrate consisting of an equimolar mixture 
(250 nM) of 120FN and either the NH~-terminal 29FN or 
the COOH-terminal 33/66FN, and analyzed secreted col- 
lagenase after 18 h. RSF plated on 120FN secreted fivefold 
more collagenase than RSF plated on intact FN. However, 
when cells were plated on a mixed substrate of the COOH- 
terminal 33/66FN and 120FN, the collagenase expression 
resembled that of cells on intact FN (Fig. 2, A and B). These 
data indicate that the COOH-terminal region contains infor- 
mation that can alter the signaling capacity of 120FN. In 
contrast, a mixed substrate containing the NH2-terminal 
29-kD matrix assembly domain (29FN) and I20FN was un- 
able to reconstitute he phenotype produced by intact FN, 
and collagenase expression remained elevated (Fig. 2 B). 
Neither 29FN nor 33/66FN affected collagenase expression 
when presented on the substrate together with intact FN. 
Because the 29FN fragment was unable to affect he sig- 
naling capacity of 120FN, we verified that the purified re- 
combinant fragment was biologically active in a well-estab- 
lished matrix assembly assay (McDonald et al., 1987). We 
found that the 29FN was able to block accumulation of a 
pericellular FN matrix by RSF cells (data not shown) under 
conditions previously demonstrated for human fibroblasts 
(McDonald et al., 1987), indicating that our recombinant 
29FN had biological activity. 
To determine whether the 33/66FN region is active in 
regulating collagenase expression i cis in the intact FN mol- 
ecule, we added antibodies raised against this region to RSF 
plated on intact FN. When polyclonal anti-33/66FN anti- 
bodies were included in the medium at a concentration f
100 #g/ml, the RSF were clearly affected, upregulating ex- 
pression of a 57-kD protein which was confirmed to be col- 
lagenase (MMP-I) by immunoprecipitation with collagenase 
antibody (Fig. 2 C). 
Northern blot analysis howed that the decreased expres- 
sion of collagenase protein detected on a mixed substrate of 
33/66FN and 120FN was due to a decrease in steady state 
collagenase mRNA, rather than to changes in production or 
secretion of the protein. Collagenase mRNA in RSF plated 
on 120FN + 33/66FN for 24 h was much lower than that 
present in ceils plated on 120FN, and was similar to the ex- 
pression level in cells plated on intact FN (Fig. 2 D). 
The observation that he 33/66FN COOH-terminal region 
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Figure 4. Expression of collagenase by RSF on a mixed substratum of 120FN and COOH-terminal fragments and peptides of FN. (A) 
RSF were plated in DME-LH in wells coated with FN (lane 1 ), 120FN (lane 2), 120FN + H120 (lane 3), 120FN + H95 (lane 4), 120FN 
+ H89 (lane 5), or 120FN + H0 (lane 6), and CM were analyzed by SDS-PAGE and immunoblotting with anti-collagenase mAb. Col- 
lagenase is indicated by arrows. Molecular weight markers (xl0 -3) are indicated at the left. (B) RSF were plated in DME-LH in wells 
coated with FN (lane 1), 120FN + 33/66FN (lane 2), 120FN (lane 3), 120FN + CS-I (lanes 4-6, with CS-I-OA added at 10, 50, and 
200/~g/ml) and 120FN + scrambled CS-1-OA (lanes 7and 8, with peptide [scr-CS-1] added at 50 and 200/~g/ml) and incubated for 18 h. 
CM was analyzed by immunoblotting with anti-collagenase mAb. (C) RSF were plated on mixed substrates of 120FN and COOH-terminal 
fragments or CS-1-OA peptide. Collagenase present in CM was analyzed by immunoblotting with collagenase mAb, and collagenase expres- 
sion was quantified by scanning densitometry from three to five different experiments, each in duplicate, and are shown as mean 5: SEM. 
(D) RSF were plated on a mixture of 120FN and peptides from the COOH-terminal HBD. Wells were coated with FN, 120FN, mixed 
substrates with 120FN, and OA-conjugated peptides I, II, III, IV, V, scrambled version of peptide V (scr-V), OA alone, and with peptide 
V-OA alone. CM was analyzed by immunoblotting with anti-collagenase mAb. Collagenase expression was quantified by densitometry 
from four separate experiments. 
of FN downregulated expression of collagenase induced by 
120FN was also true for the expression of two other MMPs 
induced by 120FN. The 120FN-stimulated expression of 
92-kD gelatinase (gelatinase B; MMP-9) (Fig. 3 A) and 
stromelysin-1 (MMP-3) (Fig. 3 B) was decreased to basal 
levels when the 33/66FN was present along with 120FN on 
the substrate. In contrast 72-kD gelatinase (gelatinase A; 
MMP-2), which has distinct regulation of its promoter 
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(Frisch and Morisaki, 1990; Huhtala et al., 1991) and is ex- 
pressed constitutively in RSF, even on intact FN, was not 
affected by the presence of the 33/66FN, demonstrating the 
specificity of this fragment's effect for certain genes. 
The CS-1 Peptide from the IIICS Region of FN Is 
Sufficient to Suppress the Induction of MMP by 120FN 
The 33/66FN region capable of suppressing the inductive 
effect of 120FN on MMP expression has several sequences 
that interact with the cell surface. These include the CS-1 se- 
quence of the I/ICS domain and several beparan sulfate- and 
chondroitin sulfate-binding sequences in repeats II112-14 (Fig. 
1, see Introduction section). To analyze the potential contri- 
butions of these sequences, we tested recombinant fragments 
and synthetic peptides from the major HBD and the IIICS 
regions for their ability to suppress induction of collagenase 
expression by RSF plated on 120FN. 
We first used recombinant fragments of the COOH- 
terminal HBD region with and without he complete IIICS 
sequence. On substrates prepared with 120FN and HBD 
fragments that included the CS-1 region (H120 and H89), 
RSF had low collagenase expression. However, substrates 
containing a HBD lacking the IIICS domain (H0), or a 
recombinant fragment (H95) lacking the CS-1 sequence but 
including the CS-5 sequence, were not able to suppress col- 
lagenase expression, indicating that he CS-I sequence is in- 
volved in the suppression (Fig. 4, A and C). 
We next used CS-1 peptide conjugated toOA as a substrate 
along with 120FN. The CS-1 peptide from the IIICS domain 
was able to suppress 120FN-induced collagenase expression 
(Fig. 4, B and C), an effect hat was concentration depen- 
dent: at the highest coating concentration (200 #g/ml) col- 
lagenase xpression decreased to the same low level seen 
with cells on intact FN. At this concentration a control, 
scrambled version of CS-1 peptide (scr-CS-1) had no detect- 
able effect on collagenase expression. The unconjugated CS-1 
peptide had no activity when immobilized on the substrate. 
Interestingly, when RSF were plated on a substrate consist- 
ing only of CS-1-OA, cells attached, spread and expressed 
low levels of MMP, similar to those found in cells plated on 
intact FN (Fig. 4 C). Thus, CS-1 affects the ability of 120FN 
to stimulate MMP expression, but does not have an indepen- 
dent effect on MMP levels. 
A Peptide Within the COOH-terminal HBD I~ype III 
Repeat 14 Can Stimulate MMP Expression above the 
Level Induced by 120FN Alone 
We next tested other synthetic peptides from the major 
COOH-terminal HBD (III '2-~4) for their ability to affect col- 
lagenase expression by RSF plated on 120FN. One of the six 
peptides tested, (peptide V) from the III j~ repeat, increased 
collagenase expression twofold over the already elevated ex- 
pression level found in cells plated on 120FN alone (Fig. 4 
D). This 8-amino acid peptide has strong heparin-binding 
activity and it has been shown to promote assembly of focal 
adhesions (Woods et al., 1993). The stimulatory effect of 
peptide V-OA was seen both when it was added in solution 
(200./~g/ml) and when it was coated as a substrate (200 
/~g/ml) with 120FN. The unconjugated peptide V also re- 
tained its activity when bound to the substrate (data not 
shown). Interestingly, however, when cells were plated on 
peptide V-OA as the only substrate, they attached, spread, 
but expressed basal levels of MMP similar to those ex- 
pressed by cells plated on intact FN. Also, addition of pep- 
tide-OA alone to a substrate of intact FN could not induce 
elevated levels of MMP (data not shown). The other four 
peptides from repeats 12 and 13 had no significant stimula- 
tory or suppressive effects on collagenase expression. 
Focal Contact Formation and MMP Expression Are 
Not Coordinately Regulated 
Previous studies have shown that primary human embryo 
fibroblasts can distinguish intact FN and large cell-binding 
fragments of FN, as evidenced by their ability to form focal 
contacts (Woods et al., 1986). Because primary RSF are able 
to distinguish between intact FN and the large central cell- 
binding fragment of FN, as determined by induction of col- 
lagenase expression, we next determined whether there was 
any correlation between the extent of focal contact formation 
and expression of collagenase by RSF plated on specific 
combinations ofFN fragments. We used immunocytochem- 
istry with anti-vinculin antibody to evaluate focal contact 
formation in cells plated for 18 h on substrates that affected 
the expression of collagenase (Fig. 5). RSF plated on 
120FN, which resulted in increased production of col- 
lagenase, had far fewer focal contacts than cells plated on in- 
tact FN. In contrast RSF plated on a mixed substrate con- 
taining 120FN and 33/66FN, which resulted in lower 
collagenase expression than that on 120FN alone, formed an 
extensive array of focal contacts, similar to that present in 
cells plated on intact FN. The 33/66FN contains both CS-1, 
which suppresses MMP expression when present in a sub- 
strate with 120FN, and peptide V, which stimulated MMP 
above the level expressed by RSF on 120FN alone. Peptide 
V also accounts for the focal contact-promoting activity of 
the COOH-terminal HBD (Woods et al., 1993). We there- 
fore compared the focal contact-promoting activities of CS-1 
and peptide V in RSE Addition of either OA-conjugated pep- 
tide V or CS-1 to 120FN restored formation of focal contacts 
in RSE although the focal contacts een with CS-1 were 
weaker and thinner than those seen with 33/66FN or peptide 
V in combination with 120FN (Fig. 5). These data indicate 
that although both peptides V and CS-1 are able to restore 
focal contacts, only CS-1 is able to suppress collagenase ex- 
pression when present in the substrate with 120FN. Further- 
more, MMP expression was induced in RSF under condi- 
tions in which they did (120FN + peptide V) and did not 
(120FN) form focal contacts. Therefore these two phenom- 
ena, the signaling mechanisms regulating collagenase ex- 
pression and formation of focal contacts, are not coupled. 
The ~4{31 Integrin Present on RSF 
Recognizes CS-1 and Mediates the Effects of CS-I on 
Collagenase Expression 
Our next goal was to identify the receptor involved in main- 
taining basal expression of MMP in RSE The ct4/31 integrin 
is the receptor known to interact with CS-1, and thus the 
most likely candidate to mediate the CS-l-dependent sup- 
pression ofcollagenase expression i duced by I20FN. How- 
ever, c~4/~1 expression has mainly been detected in mela- 
noma cells, cells of neural crest origin and lymphocytes, and 
there is little information on its presence infibroblasts (Hem- 
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Figure 5. Immunofluorescence localization of vinculin in RSF plated on various FN substrates. RSF were plated on coverslips coated with 
(A) FN, (B) 120FN, (C) 120FN + 33/66FN, (D) 120FN + peptide V-OA, (E) 120FN + CS-I-OA, or (F) 120FN + OA. Cells were 
incubated for 18 h, fixed, permeabilized, and stained with anti-vinculin mAb. Bar, 20/zm. 
ler et al., 1987; Wayner et al., 1989; Gailit et al., 1993). 
When we labeled the cell surface of RSF with biotin fol- 
lowed by immunoprecipitation with anti-or4 mAb, we found 
that RSF expressed considerable mounts of a4B1 integrin 
(Fig. 6). 
That the ot4B1 receptor detected on the RSF cell surface 
was functional was determined in attachment assays. When 
RSF were plated on wells coated with OA-conjugated CS-1 
peptide, they attached and spread within 30 min. This at- 
tachment could be blocked with mAb against a4 (Fig. 7). 
RSF also attached to immobilized OA-conjugated peptide V, 
but this attachment was not blocked with anti-tx4 antibody. 
These results indicated that ot4/31 receptor functions on RSF 
and is the major receptor recognizing the CS-1 sequence in
these cells. 
We then tested whether the anti-or4 mAb was able to inter- 
fere with the suppression f collagenase xpression seen 
when cells were plated on a mixed substrate of 120FN and 
fragments containing the CS-1 sequence. Pretreatment of
RSF with anti-or4 mAb, followed by plating on substrates, 
blocked the suppressive ffect on collagenase xpression 
seen on mixed substrates ofCS-1 and 120FN, or 120FN with 
COOH-terminal heparin-binding domain containing CS-1 
(H120), but had no detectable effects on expression of col- 
lagenase by cells plated on intact FN or 120FN (Fig. 8). 
Discussion 
The Interaction f the CS-1 Region of FN with the 
a4~l Integrin Regulates MMP Gene Expression 
Our group demonstrated previously that RSF adhering to in- 
tact FN express basal evels of MME In contrast, when RSF 
are exposed only to the central RGD-eontaining 120-kD 
cell-binding fragment of FN, expression is upregulated. This 
inductive signal is transduced by the o~5/~1 integrin Obrerb et 
al., 1989). These earlier data suggested that in the context 
of intact FN, the inductive signal for MMP communicated 
via cz5/~1 is suppressed by signals from other egions of FN 
interacting with other cell surface receptors. Here we report 
that the CS-1 sequence in the RICS region of FN interacting 
with the c~4/~1 integrin on RSF plays a critical role in main- 
taining the low basal evels of MMP expression characteris- 
tic of RSF in contact with intact FN. Three lines of evi- 
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Figure 6. Immunoprecipitation f 
biotinylated surface proteins with 
anti-a4 and -a5 antibodies. RSF 
were cultured for 72 h in DME 
supplemented with 10% FBS; ,~ 
ceils were biotinylated and surface- "~ 
labeled proteins analyzed by in- i~  
munoprecipitation with anti-c~4 
(lane 1) and anti-a5 (lane 2) 
mAbs, followed by non-reducing ~ ~ 
SDS-PAGE and detection by en- ~ m 
hanced chemiluminescence. The a _~_~ 
subunits are indicated by asterisks 
(*). Both the intact and proteolyti- 
cally processed forms of a4 are in- 
dicated. Molecular weight markers 
are indicated at the left. 
dence support hese conclusions. First, the presence of the 
25-amino acid CS-1 peptide in the substrate, along with 
120FN, is sufficient to promote a low level of MMP expres- 
sion by RSF, similar to that found when cells are plated on 
intact FN. Second, when larger COOH-terminal fragments 
are present on the substrate along with 120FN, only those 
containing the CS-1 sequence promote the reduced level of 
MMP expression. Finally, RSF express aknown receptor for 
the CS-1 sequence, the a4/31 integrin, and an antibody 
against the a4 subunit interferes with the ability of CS-1 to 
regulate MMP expression. 
The IIICS region of FN is a 120-amino acid segment with 
a complex alternative splicing pattern (Kornblihtt et al., 
1985; reviewed in Schwarzbauer, 1991). IIICS was identified 
originally as an attachment region for mouse melanoma cells 
(Humphries et al., 1986), but was subsequently shown also 
to support adhesion of neural crest ceils and their derivatives 
(Dufour et al., 1988; Berdnarczyk and Mclntyre, 1992), 
lymphocytes (Wayner et al., 1989; Guan and Hynes, 1990), 
and dermal fibroblasts (Gailit et al., 1993). IIICS has two 
binding sites for the a4/~l integrin: CS-1 and CS-5 sites, of 
I I 
Figure 8. Anti-c~4 mAb blocks the ability of CS-I and HI20 to sup- 
press induction by120FN of collagenase expression in RSE RSF 
were treated with anti-a4 mAb (5 t~g/ml) for 30 min before plating 
them in DME-LH in wells coated with various substrates. RSF with 
or without anti-a4 treatment were plated on FN, 120FN, 120FN 
+ CS-1-OA, and 120FN + H120. CM was analyzed b  SDS-PAGE 
and immunoblotting with anti-collagenase mAb. Collagenase ex- 
pression was quantified by densitometry from six separate experi- 
ments, each in duplicate, and is shown as me n + SEM. 
which the CS-1 has the higher binding affinity (Mould et al., 
1991). Both of these regions can be independently included 
or excluded from the IIICS region as a consequence ofalter- 
native splicing. The IIICS region containing CS-1 is included 
in >50% of the FN secreted by fibroblasts in culture, and 
transformed fibroblasts have been shown to exhibit even 
higher levels of FN containing CS-1 (Castellani et al., 1986; 
Figure 7. RSF adhesion to CS-I and peptide 
V. RSF were treated with anti-a4 mAb 
prior to plating in wells coated with OA- 
conjugated CS-I or peptide V. Cells were 
incubated for 30 min and plates were 
shaken at 250 rpm for 30 s. (,4) Control RSF 
on CS-I-OA, (B) RSF with anti-a4 mAb on 
CS-1-OA after shaking, (C) control RSF on 
peptide V-OA, (D) RSF with anti-a4 mAb 
on peptide V-OA after shaking. 
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Hershberger and Culp, 1990), Even though all FN isoforms 
also contain another low-affinity 0~4/31-binding site, HI in the 
IH t4 segment of the COOH-terminal HBD (Mould and 
Humphries, 1991), our present studies with H95, H89 and 
H0 fragments reported here suggest that MMP regulation via 
a4/31 involves only the CS-1 sequence. 
The c~4/51 integrin is not expressed ubiquitously. This cell 
surface receptor is present in melanoma cells, lymphocytes 
and neural crest ceils, although previous reports have shown 
that some cultured fibroblasts express o~4/~1 (Gailit et al., 
1993). Our data suggest that regulated expression of ot4131, 
concomitant with selective xpression of FN splice variants 
that contain binding sites for ot4~31, could contribute to the 
regulation of MMP expression spatially and temporally. 
Several Regions of F~bronectin Contribute to 
Regulating the Level of MMP Expression in RSF 
Our data document critical and antagonistic roles for CS-1 
and the RGD binding region of the central cell-binding do- 
main (120FN) in the regulation of MMP gene expression by 
FN. However, ot4/~l mAb, which was able to interfere with 
the ability of CS-1 to regulate MMP expression on mixed 
substrates of 120FN + CS-1 and 120FN + H120, could not 
overcome the suppressive effects on MMP expression of in- 
tact FN, suggesting that other egions of FN, at least in cis, 
may play a role in the regulation of MMP expression on in- 
tact FN. 
Interestingly the 33/66FN, comprised of both the COOH- 
terminal HBD (repeats III ~2-~4) and IUCS, also contains 
MMP-inductive (peptide V) as well as MMP-suppressive 
regions (CS-1). Peptide V, an 8-amino acid sequence in 
III ~4, stimulated MMP expression further when present in 
the substrate along with 120FN. The observation that the 
whole 33/66FN is suppressive, whereas recombinant COOH- 
terminal fragments lacking CS-1 and containing peptide V 
are inductive, suggests hat in the context of the whole COOH- 
terminal region the suppressive signal from CS-1 is domi- 
nant, when presented on the substrate with 120FN. In addi- 
tion, peptide V was not inductive by itself when plated in the 
absence of 120FN, suggesting that its effect on MMP expres- 
sion is indirect. Addition of peptide V in the context of intact 
FN did not induce elevated levels of MMP. A receptor that 
binds to the peptide V sequence has not been identified. 
In addition to c~4B1 and 0~5/~1 integrins RSF express other 
receptors for FN, including otv-containing integrins, which 
also recognize the RGD sequence, and cell-surface pro- 
teoglycans. Anti-otv/~3 mAb (LM609) and anti-c~5 mAb 
(BIIG2) can block cell adhesion to 120FN (Tremble t al., 
1994) but not to intact FN, which allows the additional inter- 
action between c~4/~1 and CS-1. However, ~v/~3 is prob- 
ably not involved in the inductive signal that stimulates 
MMP expression i RSF plated on 120FN, because RSF in- 
teraction with immobilized anti-~5 mAb, but not with im- 
mobilized anti-c~v/~3 mAb, stimulates MMP (Werb et al., 
1989; Tremble, P. M., and Z. Werb, unpublished observa- 
tions). Whether otv/~3 or other integrins can participate, in 
addition to c~4fll, in the regulation of MMP by intact FN was 
not addressed, but cannot be ruled out. 
Integrins are not the only cell-surface r ceptors that medi- 
ate the effects of FN on the regulation of MMP expression 
in RSE Treatment of RSF with heparan sulfate, chondroitin 
sulfate, or heparatinase III before plating them on intact FN 
increases the expression of collagenase tothe level seen with 
120FN (Tremble et al., 1994; and unpublished observa- 
tions). This suggests that both cell surface heparan sulfate 
and chondroitin sulfate may be involved in the suppression 
of MMP expression on intact FN. However, neither the 
whole I-IBD (II112-t4) without he CS-1 sequence, nor any of 
the peptides containing heparan- and chondroitin sulfate- 
binding sites in the COOH-terminal HBD region that we 
tested were able to suppress MMP expression when added 
in trans with 120FN, Previous tudies have shown that mela- 
noma cell adhesion to CS-1 mediated by ot4131 can be partly 
inhibited by interfering with CSPG synthesis or expression. 
Since these molecules do not bind CS-1, they may instead 
modify the function and activity of ot4B1 integrin (Iida et al., 
1992). Thus, it is possible that proteoglycans participate in 
collagenase r gulation indirectly by modifying integrin ac- 
tivities. Cell surface proteoglycans do, however, appear to be 
directly involved in the regulation of focal contact assembly 
(Couchman et al., 1988; LeBaron et al., 1988; Woods et al., 
1993). 
Focal Contact Formation and Collagenase Expression 
Are Regulated Independently in RSF 
Although the physiological role of the peptide V sequence 
in intact FN is not clear, our studies with this peptide and 
CS-l-containing fragments of FN have allowed us to demon- 
strate that wo important responses to FN-assembly of focal 
contacts and regulation of MMP gene expression-involve 
distinct signaling processes. Peptide V has been shown pre- 
viously to be the active focal adhesion-promoting peptide in 
the lII ~2-~4 HBD of FN (Woods et al., 1993). Our present 
studies how that peptide V both stimulated MMP expres- 
sion and restored focal contact formation in RSF plated on 
120FN. Furthermore, CS-1 also promoted focal contact for- 
mation by RSF when presented in trans with 120FN, but it 
suppressed MMP levels. Thus, RSF can assemble focal con- 
tacts under plating conditions that promote low (intact FN 
or 120FN + CS-1) or high (120FN, or 120FN + peptide V) 
MMP expression levels (see Table I). Previous tudies have 
shown clearly that localization of integrins to focal contacts 
is mediated via the/5'1 subunit of c~/~l complexes (LaFlamme 
et al., 1992; Reszka et al., 1992), with ~ subunits playing 
a permissive, but not instructive role. Our present studies 
suggest that he integrin c~ subunits may play active roles in 
regulating signaling pathways leading to altered MMP gene 
expression. 
Cell Surface Receptors Collaborate in Regulating 
MMP Expression 
In the present study we show that signaling by the ¢x5/~1 and 
oe4/~l integrins, which recognize distinct domains on FN, 
regulates MMP expression i response to FN. When exam- 
ined individually, these two interactions signal opposing 
effects on MMP expression. When only ot5/~l is engaged by 
120FN or immobilized anti-~5 antibody, MMP expression 
is stimulated. When only a4/~l is engaged by CS-1, expres- 
sion is low. However, when both these receptors interact with 
their respective domains, MMP expression is also low. We 
hypothesize that engagement of c~4/~1 with its ligand inter- 
feres with the inductive signal from the otS/~I-RGD interac- 
tion. One possibility isthat he engagement of ¢x4~1 with CS-1 
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Table I. Expression of Collagenase and Formation of Focal 
Contacts by RSF on Fibronectin Substrates 
Substrate Collagenase Focal contacts 
FN - + + 
120FN + - 
120FN + 33/66FN - ++ 
120FN + CS-1 - + 
120FN + peptide V + + + + 
generates an independent signaling pathway that intersects 
and interferes with the inductive signal from ot5fll. Because 
previous studies comparing monovalent and polyvalent 
ligands or antibodies demonstrated that the MMP-inductive 
signal from ot5/$1 requires integrin clustering, it is possible 
that when both integrins are occupied, effective ot5fll 
clustering is blocked. A recent report has suggested that 
when u4~l is in an activated state, it can recognize the RGD 
sequence (Sanchez-Aparicio et al., 1994). Therefore, an- 
other possibility is that when they are both engaged, the two 
integrins form mixed clusters as they compete for available 
RGD sites. These mixed clusters may be ineffective at signal- 
ing elevated MMP, while still being able to promote attach- 
ment, spreading and cytoskeletal reorganization. Studies to 
determine the presence of specific o~ subunits in focal con- 
tacts and their correlation with downregulation f MMPs are 
in progress. 
Understanding how signals from the different integrin 
receptors affect MMP gene expression will require detailed 
knowledge of the signal transduction pathways initiated un- 
der these conditions. In studies to be reported elsewhere we 
determined that the nuclear signaling pathway in the MMP 
induction cascade initiated by 120FN, or by anti-or5 interac- 
tions with a5/~1, requires induction of c-fos mRNA and nu- 
clear translocation of c-Jun and c-Fos proteins, and engage- 
ment of AP-1 and PEA-3 sites in the collagenase promoter 
(Tremble, E, C. Damsky, Z. Werb, manuscript submitted 
for publication). Furthermore, RSF binding to 120FN trig- 
gers distinct patterns of tyrosine phosphorylation within the 
first 5 min of attachment as compared to intact FN (Tremble, 
E, and Z. Werb, 1992. Mol. Biol. Cell Suppl. 3:95a). Nei- 
ther the signaling pathway from t~4(31 nor the mechanism 
by which signaling through ol4/~1 intersects with the ct5/~1 
pathway has been elucidated. However, others have shown 
that tyrosine phosphorylation of a 105-kD protein can be 
triggered in response to binding T cells and melanoma cells 
to CS-1 via c~4B1 (Nojima et al., 1992; Garratt, A. N., and 
M. J. Humphries, manuscript in preparation). Interestingly, 
binding of ct4/31-bearing lymphocytes to VCAM-1 on en- 
dothelium has also been shown to stimulate proteinase x- 
pression in lymphocytes (Romanic and Madri, 1994). 
How Might Fibronectin-Cell Interactions Contribute 
to Regulation of ECM Remodeling? 
Controlled spatial and temporal expression of MMP is es- 
sential for migration of normal cells and physiological 
remodeling of normal tissues (e.g., mammary gland, uterus) 
(reviewed in Alexander and Werb, 1991; Ashkenas et al., 
1994). Aberrant regulation of MMPs is a hallmark of many 
pathologic onditions, such as tumor cell invasion (Liotta et 
al., 1991; Hart and Saini, 1992), destruction of connective 
tissues in arthritis (Vincenti et al., 1994), and chronic non- 
healing wounds (Wysocki et al., 1993). Fragments of FN and 
elevated expression of MMPs are found at sites of inflamma- 
tion, in wound fluid (Grinnell et al., 1992) and in synovial 
fluid in osteoarthritis (Xie et al., 1992). Such fragments 
could be similar in activity to 120FN and may further induce 
MMP expression and tissue destruction. Whether COOH- 
terminal fragments of FN containing the CS-1 sequence or 
peptide V are present in such sites is as yet unknown. 
The information that cells derive from FN can be changed, 
not just by fragmentation fFN, but also by the presence or 
absence of other tightly regulated ECM components hat in- 
teract with FN. Tenascin, a protein expressed in regions of 
tissue during ECM remodeling and cell migration, increases 
MMP expression by RSF in vitro when it is presented to- 
gether with FN on the substrate, although not in combination 
with other ECM components (Tremble et al., 1994). One 
possibility is that interaction of tenascin with either FN or 
its cell-surface receptors interferes with the FN-ot4/$1 inter- 
action permitting the ~5fll-RGD interaction that signals in- 
creased MMP expression, 
Interestingly, both ot4~l and the CS-1 region of FN have 
been implicated in the metastatic behavior of tumor cells. 
The CS-1 peptide has been shown to block experimental lung 
metastasis when co-injected intravenously with B16 mela- 
noma cells (Saiki et al., 1990). Although the peptide is 
thought o act by interfering with cell binding to substrates, 
an alternative explanation may be that it affects MMP expres- 
sion, and thereby the capacity of melanoma cells to invade. 
Moreover the invasiveness ofmelanoma cells (B16) that lack 
ot4fll is reduced by transfection of or4, which enhances 
cell-cell interaction and, presumably, reduces the escape of 
ceils from the tumor mass (Qian et al., 1994). It is possible 
that MMP expression is also affected. 
In summary, results presented in this study show that sig- 
nals modulating MMP gene expression and focal contact as- 
sembly are regulated independently, and that cooperative 
signaling by two integrin receptors plays the dominant role 
in regulating expression of an important class of ECM- 
remodeling enes by FN. Taken together, this work illus- 
trates directly the modular way in which information in the 
ECM is detected and processed by cell-surface receptors. 
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